Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial

BACKGROUND AND THE PURPOSE OF THE STUDY: Diabetic neuropathy is the most common diabetic complication that often is accompanied by significant morbidity, mortality and economic burden. The purpose of this study was evaluation of effect of Semelil (ANGIPARS™), a new herbal drug for treatment of diabe...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bakhshayeshi, S., Madani, SP., Hemmatabadi, M., Heshmat, R., Larijani, B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Tehran University of Medical Sciences 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232074/
https://ncbi.nlm.nih.gov/pubmed/22615641
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak